Leaflet IVACAFTOR SUN 150mg film-coated tablets

Product code:
W71552001
Quantity:
28
Indicated for:
cystic fibrosis
Route of administration:
oral
Substance:
ivacaftor (CFTR modulator)
ATC
R07AX02 — Respiratory system | Other respiratory system products | Other respiratory system products
Ivacaftor is a medication used for the treatment of cystic fibrosis in patients with specific CFTR gene mutations. It works by improving the function of the CFTR protein, facilitating chloride transport across cell membranes.

The medication is taken orally, usually twice daily with fat-containing food, as directed by a doctor. It is important to follow the treatment regimen to achieve the best results.

Side effects may include headache, abdominal pain, diarrhea, or skin rashes. In rare cases, severe hepatic reactions or elevated liver enzymes may occur.

Ivacaftor is not recommended for patients with hypersensitivity to this medication or severe hepatic impairment.

General data about IVACAFTOR SUN 150mg

Substance:
ivacaftor
Date of latest medicines list:
01-01-2026
Product code:
W71552001
Concentration:
150mg
Pharmaceutical form:
film-coated tablets
Quantity:
28
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
TERAPIA S.A - ROMANIA
Holder:
SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V. - TARILE DE JOS
Number:
16341/2025/01
Shelf life:
3 years

Pharmaceutical forms available for ivacaftor

Concentrations available for ivacaftor

  • 150mg
  • 25mg
  • 50mg
  • 59.5mg
  • 75mg